IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 196 filers reported holding IMPAX LABORATORIES INC in Q3 2015. The put-call ratio across all filers is 2.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $515,000 | -10.9% | 26,502 | -23.7% | 0.03% | -3.2% |
| Q4 2017 | $578,000 | -25.1% | 34,733 | -8.7% | 0.03% | -27.9% |
| Q3 2017 | $772,000 | +957.5% | 38,042 | +738.9% | 0.04% | +760.0% |
| Q2 2017 | $73,000 | -54.1% | 4,535 | -62.2% | 0.01% | -61.5% |
| Q4 2016 | $159,000 | -63.4% | 12,000 | -34.5% | 0.01% | -53.6% |
| Q3 2016 | $434,000 | -41.2% | 18,311 | -28.5% | 0.03% | -34.9% |
| Q2 2016 | $738,000 | -43.8% | 25,614 | -16.6% | 0.04% | -44.2% |
| Q4 2015 | $1,312,000 | -59.7% | 30,694 | -66.8% | 0.08% | -53.3% |
| Q3 2015 | $3,257,000 | +112.3% | 92,506 | +176.8% | 0.16% | +120.0% |
| Q2 2015 | $1,534,000 | +121.0% | 33,414 | +125.5% | 0.08% | +120.6% |
| Q1 2015 | $694,000 | +166.9% | 14,815 | +80.7% | 0.03% | +142.9% |
| Q4 2014 | $260,000 | +26.8% | 8,200 | +20.2% | 0.01% | +16.7% |
| Q2 2014 | $205,000 | – | 6,821 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |